Company Analysis

VistaGen Therapeutics, Inc. (VTGN)

Nasdaq: VTGN · Pharmaceutical Preparations · South San Francisco, CA · filing with the SEC since 2007
Grade4.8
◀ Past 2.9● Present 4.0▶ Future 6.6
1 est.

Who runs VistaGen Therapeutics, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Singh Shawn
President and CEO. First filing May 2011, latest Jul 2, 2026, 1 filing in all.
Officers reporting now
8
of 14 people with a filing in the last fifteen months
Directors reporting now
6
21 people on the record since 2011
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Singh ShawnPresident and CEOMay 2011Jul 2, 2026none
Tressler Nick B.Chief Financial OfficerDec 2025Jul 2, 2026none
Adler Reid G.Chief Legal OfficerMay 2022Jul 2, 2026none
Angelov Angel SChief Medical OfficerMay 2026May 19, 2026none
Prince Joshua S.Chief Operating OfficerNov 2023Apr 9, 2026none
Cote Elissa S.Chief Corp Development OfficerJun 2025Apr 9, 2026none
Cunningham Ann MichelleCHIEF COMMERCIAL OFFICERJan 2019Sep 11, 2025none
Anderson Cynthia LynnCHIEF FINANCIAL OFFICERAug 2023Jul 1, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Williamson Douglas JdirectorJul 2026Jul 31, 2026none
Edick Paul RdirectorNov 2025Nov 4, 2025none
Curley JoannedirectorApr 2021Sep 11, 2025none
Fitzpatrick Margaret MdirectorJul 2021Sep 11, 2025none
Rotunno Mary L.directorJul 2021Sep 11, 2025none
Saxe Jon SdirectorMay 2011Sep 11, 2025none
Earlier names on the record18, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton VTGN · research, not advice